BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Neurology

Harbour BioMed and Insilico Medicine Partner to Accelerate AI-Driven Antibody Discovery

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on...

February 21, 2025 | News

Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute’s CNS Capsids to Advance Gene Therapy for Neurological Diseases

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expand...

February 21, 2025 | News

Paradromics and Saudi Arabia’s NEOM Partner to Transform Brain-Computer Interface Therapies

Paradromics, Inc., a global leader in high-data rate brain-computer interface (BCI) technology, announced a strategic investment from NEOM, the sustainable...

February 13, 2025 | News

Thermo Fisher Scientific Introduces Invitrogen™ EVOS™ S1000 for Advanced Spatial Tissue Imaging

Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advance...

February 13, 2025 | News

WHO Grants ‘Emestedastat’ as the Official INN for Actinogen’s Xanamem®, a First-in-Class Cortisol Regulator

Actinogen Medical Limited (ASX: ACW) has announced that the World Health Organization (WHO) has granted the nonproprietary name ‘emestedastat...

February 06, 2025 | News

Argent BioPharma’s CannEpil® Offers New Hope for Drug-Resistant Epilepsy Patients

Argent BioPharma Limited (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company, is pioneering a transformative approach to drug-resistant e...

February 06, 2025 | News

Corcept Therapeutics Submits NDA for Relacorilant to FDA for Cushing’s Syndrome Treatment

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocr...

January 01, 2025 | News

GNT Pharma Announces Promising Nelonemdaz Results, Initiates Global Phase 3 Stroke Trials

** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Mult...

December 12, 2024 | News

Actinogen Expands Alzheimer’s Trial Across Australia and US, Eyes Interim Results in 2025

Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial Officer, Andrew Udell X...

December 10, 2024 | News

SNUBH, CurePSP, and GemVax Unite to Establish Korea’s First International PSP Research and Treatment Center

MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment Center Tackling Global Challenges in an Aging Er...

December 10, 2024 | News

Alamar Biosciences Expands to APAC with ARGO™ HT System Installation at HKCeND

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce its commercial presence in th...

December 09, 2024 | News

ShiraTronics Launches Pivotal RELIEV-CM2 Trial with First Neuromodulation Implants for Chronic Migraine in the U.S. and Australia

First Implants of Innovative Device Completed in the United States and Australia ShiraTronics, a clinical-stage innovator in neuromodulatio...

December 04, 2024 | News

Serina Therapeutics Secures $10 Million Equity Financing from JuvVentures to Advance Parkinson's Therapy

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, announced a $10 million equity fi...

December 03, 2024 | News

Eisai and Biogen Japan Partner with NCNP for APOE Genetic Testing in Alzheimer’s Research

Eisai Co., Ltd. and Biogen Japan Ltd. announced that Eisai has entered into a research collaboration agreement with the National Center of Neurology and Ps...

November 27, 2024 | News

Stay Connected